Lyndon McLeod wrote a 1.2 million-word “novel” — with real names, real grudges, and real murders plotted out years in advance. In 2021, he carried out those killings across Denver, targeting women and ...

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

The agency greenlit an oral version of the obesity drug Wegovy. By Dani Blum The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

Food and Drug Administration’s approval hands drugmaker Novo Nordisk an edge in the race to market an obesity pill US regulators on Monday gave the green light to a pill version of the blockbuster ...

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO), opens new tab newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing cash-paying consumer market, with plans ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S.

“This is a convenient method for patients to use pills they already have,” she says. Both doses of pills should be taken as soon as possible, ideally within 72 hours (three days) of unprotected sex, ...